These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 13763007)

  • 1. Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
    LOCKWOOD CH
    Can Med Assoc J; 1961 Sep; 85(11):631-7. PubMed ID: 13763007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spirolactone (Aldactone) in ascites caused by liver cirrhosis].
    van DOMMELEN C; LE POOLE A; VAANDRAGER H; SCHOPMAN W; WADMAN SK
    Ned Tijdschr Geneeskd; 1962 Jul; 106():1481-6. PubMed ID: 13887135
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of the hydrosaline retention in hepatic cirrhosis with spironolactone].
    VELASCO M; GAZMURI R; KATZ R
    Rev Med Chil; 1961 Oct; 89():846-51. PubMed ID: 13925219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comments on the use of spirolactones in the treatment of ascitic cirrhosis (5 cases)].
    GRILLIAT JP; MARCHAL C; ANTOINE ; SAPELIER P; KIFFER B
    Rev Med Nancy; 1961; 86():801-20. PubMed ID: 13901929
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
    BONINI A
    Minerva Med; 1962 Jun; 53():1990-4. PubMed ID: 13871015
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.
    KERR DN; READ AE; HASLAM RM; SHERLOCK S
    Lancet; 1958 Nov; 2(7056):1084-7. PubMed ID: 13599489
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E; PROTIN M
    J Sci Med Lille; 1962 May; 80():225-35. PubMed ID: 14483183
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spirolactone treatment of liver cirrhosis with edema and ascites].
    OFSTAD J; SIGSTAD H
    Nord Med; 1962 Jan; 67():21-4. PubMed ID: 14481210
    [No Abstract]   [Full Text] [Related]  

  • 9. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CIRRHOTIC ASCITIS].
    GARCIA-RAMOSARRIAGA J
    Acta Med Tenerife; 1963; 20():101-4. PubMed ID: 14093724
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical management of ascites in cirrhosis of the liver. II. Aldosterone antagonists.
    RIVERA A; VELASCO F; SUAREZ MA; DIES F
    Clin Pharmacol Ther; 1963; 4():154-61. PubMed ID: 13974133
    [No Abstract]   [Full Text] [Related]  

  • 11. [LIMITS OF TREATMENT OF CIRRHOSIS WITH DIURETICS (SALDIURETICS AND ALDOSTERONE ANTAGONISTS)].
    ALBEAUX-FERNET M; ROMANI JD
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1277-84. PubMed ID: 14098211
    [No Abstract]   [Full Text] [Related]  

  • 12. [Trials of treatment of cirrhotic ascites with a spirolactone. Apropos of 7 cases].
    LEVRAT M; BRETTE R; FRANCOIS B; TISSOT A; MESTRALLET G
    Lyon Med; 1961 May; 93():1115-23. PubMed ID: 13761576
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.
    Bernardi M; Servadei D; Trevisani F; Rusticali AG; Gasbarrini G
    Digestion; 1985; 31(4):189-93. PubMed ID: 4007290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the ascites and edema of cirrhotics by spironolactone].
    MINICONI P; BOURREILLE J; SUDUCA P; CARAYON P; LAVOCAT G; ISSAD H
    Alger Medicale; 1962 Jan; 66():1-98. PubMed ID: 14474319
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cirrhotic edemas and spironolactone].
    ALBAHARY C; POMMEY B
    Concours Med; 1962 Mar; 84():1759-66. PubMed ID: 13860028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aldactone (antialdosterone SC-9420) in the treatment of the edema of cardiac and cirrhoticpatients. Bioclinical study. I].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E
    Ann Biol Clin (Paris); 1962; 20():497-524. PubMed ID: 14483184
    [No Abstract]   [Full Text] [Related]  

  • 17. THE TREATMENT OF CIRRHOTIC ASCITES.
    SHALDON S
    Acta Gastroenterol Belg; 1963; 26():558-71. PubMed ID: 14083742
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CIRRHOTIC ASCITIS].
    GARCIA RAMOSARRIAGA J
    Rev Esp Enferm Apar Dig Nutr; 1963 Oct; 22():1088-91. PubMed ID: 14112555
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the mechanism and treatment of ascites in hepatic cirrhosis.
    CHEY WY; SHAY H
    Am J Med Sci; 1962 Jul; 244():1-15. PubMed ID: 13878847
    [No Abstract]   [Full Text] [Related]  

  • 20. [HOW TO TREAT CIRRHOTIC ASCITES IN 1963].
    RUYTERS L
    Rev Med Liege; 1963 Dec; 18():783-7. PubMed ID: 14105757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.